EUCTR2007-001611-32-NL
进行中（未招募）
1 期
A multi-center cardiac safety study of subjects who participated in Organon sponsored Phase 1 and Phase 2 completed and discontinued trials with Org 24448 (Protocols: 22601;22602;22603; 153001;153002;153003;153004, 29402; III.04.0311).
V Organon0 个研究点目标入组 295 人2008年4月29日
概览
- 阶段
- 1 期
- 干预措施
- 未指定
- 疾病 / 适应症
- 未指定
- 发起方
- V Organon
- 入组人数
- 295
- 状态
- 进行中（未招募）
- 最后更新
- 6年前
概览
简要总结
暂无简介。
研究者
入排标准
入选标准
- •Subjects must:
- •1\. be verified by the investigator to have participated in a previous Organon sponsored Org 24448 trial
- •2\. sign an affirmative informed consent before evaluations are conducted;
- •Are the trial subjects under 18? no
- •Number of subjects for this age range:
- •F.1\.2 Adults (18\-64 years) yes
- •F.1\.2\.1 Number of subjects for this age range
- •F.1\.3 Elderly (\>\=65 years) yes
- •F.1\.3\.1 Number of subjects for this age range
排除标准
- •Subjects must not have:
- •1\. have a concurrent acute condition that could interfere the conduct or interpretation of the evaluations. (e.g. acute psychosis, respiratory illness; current experimental medications) if possible evaluation of such subjects is deferred until resolution of such conditions.
结局指标
主要结局
未指定
相似试验
未知
3 期
A multicenter investigative study of the safety and efficacy of long-term administration of aripiprazole in combination with mood stabilizer for the treatment of patients with bipolar disorder experiencing a manic or mixed episodeAcute manic and mixed episodes associated with Bipolar I DisorderJPRN-jRCT2080220516Otsuka Pharmaceutical Co., Ltd.
招募中
不适用
Prospective multicenter study regarding the safety of surgical results of laparoscopic pancreatic resection; Japanese Society for Endoscopic Pancreatic Surgery, Japanese Society of Hepato-Biliary-Pancreatic Surgery, and Japan Society for Endoscopic Surgery cooperative studyPancreatobiliary diseases (Patients planned to undergo laparoscopic pancreatic resection)JPRN-UMIN000022836Japanese Society for Endoscopic Pancreatic Surgery3,000
进行中（未招募）
不适用
Multizentrische Studie über die Cardiotoxizität von R-CHOP (Rituximab, Cyclophosphamid, Doxorubicin, Vincristin und Prednisolon) v. R-COMP (Rituximab, Cyclophosphamid, liposomalem Doxorubicin, Vincristin und Prednisolon) bei Patienten mit Diffus Großzelligem B-Zell Lymphon (NHL-14)EUCTR2007-004970-24-ATAGMT - Arbeitsgemeinschaft Medikamentöse Tumortherapie Gemeinnützige GmbH80
已完成
不适用
Multicenter Clinical Study Evaluating the Safety and Efficacy of Dasatinib Treatment and its Discontinuation in Patients with Chronic Phase Chronic Myelogenous Leukemia who had Reached Complete Molecular Response during Imatinib TherapyChronic Phase Chronic Myelogenous LeukemiaJPRN-UMIN000007221Juntendo University School of Medicine40
进行中（未招募）
不适用
A medical follow-up study in patients who received BGG492 for more than 28 days.Testing for adrenal cortical adenomas in male and female patientsTesting for uterine endometrial stromal sarcromas in all female patientsTherapeutic area: Diseases [C] - Cancer [C04]EUCTR2013-003431-29-ITovartis Farma S.p.A.77